COVID-19 and the small intestine
- 作者: Bakharev S.1, Baulo E.1, Bykova S.1, Dbar S.1, Parfenov A.1
-
隶属关系:
- Loginov Moscow Clinical Scientific Center
- 期: 卷 93, 编号 3 (2021)
- 页面: 343-347
- 栏目: Reviews
- URL: https://journals.rcsi.science/0040-3660/article/view/64981
- DOI: https://doi.org/10.26442/00403660.2021.03.200662
- ID: 64981
如何引用文章
全文:
详细
The SARS-CoV-2 virus enters the body through the angiotensin-converting enzyme 2 (ACE-2), which is the entry point of the virus into the cell. The most dense fabric of ACE-2 is the lungs. The small intestine also contains large amounts of ACE-2 in the enterocyte membrane and is often involved in this process. Intestinal symptoms can appear at different stages of the disease. The review describes the mechanisms of interaction of SARS-CoV-2 with enterocytes, the fecal-oral route of infection, diagnosis and treatment of COVID-19 with intestinal symptoms.
作者简介
Sergei Bakharev
Loginov Moscow Clinical Scientific Center
Email: asfold@mail.ru
ORCID iD: 0000-0003-2213-6147
врач-гастроэнтеролог отд-ния невоспалительной патологии кишечника
俄罗斯联邦, MoscowElena Baulo
Loginov Moscow Clinical Scientific Center
Email: asfold@mail.ru
ORCID iD: 0000-0002-8300-7608
мл. науч. сотр. отд-ния невоспалительной патологии кишечника
俄罗斯联邦, MoscowSvetlana Bykova
Loginov Moscow Clinical Scientific Center
Email: asfold@mail.ru
ORCID iD: 0000-0001-9576-2953
к.м.н., зав. отд-нием невоспалительной патологии кишечника
俄罗斯联邦, MoscowSaria Dbar
Loginov Moscow Clinical Scientific Center
Email: asfold@mail.ru
ORCID iD: 0000-0001-6516-7782
мл. науч. сотр. отд-ния невоспалительной патологии кишечника
俄罗斯联邦, MoscowAsfold Parfenov
Loginov Moscow Clinical Scientific Center
编辑信件的主要联系方式.
Email: asfold@mail.ru
ORCID iD: 0000-0002-9782-4860
д.м.н., проф., зав. отд. патологии кишечника
俄罗斯联邦, Moscow参考
- Decaro N, Desario C, Elia G, et al. Serological and molecular evidence that canine respiratory coronavirus is circulating in Italy. Vet Microbiol. 2007;121(3-4):225-30. doi: 10.1016/j.vetmic.2006.12.001
- Totura AL, Bavari S. Broad-spectrum coronavirus antiviral drug discovery. Expert Opin Drug Dis. 2019;14(4):397-412. doi: 10.1080/17460441.2019.1581171
- Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1977-85. doi: 10.1056/NEJMoa030666
- Drosten C, Günther S, Preiser W, et al. Identifcation of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967-76. doi: 10.1056/NEJMoa030747
- Jevšnik M, Steyer A, Pokorn M, et al. The Role of Human coronaviruses in Children Hospitalized for Acute Bronchiolitis, Acute Gastroenteritis, and Febrile Seizures: A 2-Year Prospective Study. PLoS One. 2016;11(5):e0155555. doi: 10.1371/journal.pone.0155555
- Chiu SS, Chan KH, Chu KW, et al. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis. 2005;40(12):1721-9. doi: 10.1086/430301
- Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. doi: 10.1038/s41586-020-2012-7
- Coronavirus disease 2019 (COVID-19) Situation Report – 39 1-7. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200228-sitrep-39-covid-19.pdf?sfvrsn=aa1b80a7_4
- Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of coronavirus Disease 2019 in China. N Engl J Med. 2020. doi: 10.1056/NEJMoa2002032
- Song Y, Liu P, Shi XL, et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020. doi: 10.1136/gutjnl-2020-320891
- Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386-9.doi: 10.1080/22221751.2020.1729071
- Perlot T, Penninger JM. ACE2 – from the renin-angiotensin system to gut microbiota and malnutrition. Microbes Infect. 2013;15(13):866-73. doi: 10.1016/j.micinf.2013.08.003
- Camargo SM, Singer D, Makrides V, et al. Tissue-specifc amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology. 2009;136(3):872-82.doi: 10.1053/j.gastro.2008.10.055
- Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2):622-30. doi: 10.1002/path.1560
- Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A frst step in understanding SARS pathogenesis. J Pathol. 2004;203:631-7.doi: 10.1002/path.1570
- Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875-9. doi: 10.1038/nm1267
- To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol. 2004;203:740-3. doi: 10.1002/path.1597
- Mönkemüller K, Fry LC, Rickes S. COVID-19, coronavirus, SARS-CoV-2 and the small bowel. Rev Esp Enferm Dig. 2020;112(5):383-8. doi: 10.17235/reed.2020.7137/2020
- Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009;7(6):439-50.doi: 10.1038/nrmicro2147
- Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614-21.doi: 10.1128/JVI.79.23.14614-14621.2005
- Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of the SARSCoV-2 by full-length human ACE2. Science. 2020.doi: 10.1126/science. abb2762
- Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260-3. doi:: 10.1126/science.abb2507
- Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020.doi: 10.1016/j.cell.2020.02.052
- Klimpel KR, Molloy SS, Thomas G, et al. Anthrax toxin protective antigen is activated by a cell-surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci USA. 1992;89:10277-81. doi: 10.1073/pnas.89.21.10277
- Danilczyk U, Penninger JM. Angiotensin-converting enzyme II in the heart and the kidney. Circ Res. 2006;98(4):463-71. doi: 10.1161/01. RES.0000205761.22353.5f
- Kleta R, Romeo E, Ristic Z, et al. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet. 2004;36(9):999-1002.doi: 10.1038/ng1405
- Hashimoto T, Perlot T, Rehman A, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477-81. doi: 10.1038/nature11228
- Leung WK, To KF, Chan PK, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125(4):1011-7. doi: 10.1016/j.gastro.2003.08.001
- Effenberger M, Grabherr F, Mayr L, et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020;69(8):1543-44.doi: 10.1136/gutjnl-2020-321388
- Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831-3.doi: 10.1053/j.gastro.2020.02.055. e11833
- Shi X, Gong E, Gao D, et al. Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases. Am J Gastroenterol. 2005;100(1):169-76. doi: 10.1111/j.1572-0241.2005.40377.x
- D’Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol. 2020;18(8):1663-72.doi: 10.1016/j.cgh.2020.04.001
- Ahmed M. Coronavirus Disease 2019: A Gastroenterologist’s Perspective in May 2020. Gastroenterology Res. 2020;13(3):89-95.doi: 10.14740/gr1292
- Ai J-W, Zi H, Wang Y, et al. Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms: An Analysis of Seven Patients in China. Front Med. 2020;9(7):308. doi: 10.3389/fmed.2020.00308
- Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488-94. doi: 10.1001/jama.2020.3204
- Yang ZW, Li GW, Dai XL, et al. Three cases of COVID- 19 pharyngeal swab were still positive for fecal nucleic acid. Chinese J Digest. 2000:40
- Chen L, Lou J, Bai Y, Wang M. COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests. Am J Gastroenterol. 2020;115(5):790. doi: 10.14309/ajg.0000000000000610
- Mao R. Expert consensus on diagnosis and treatment of COVID-19 digestive system. Chin J Nat Med. 2020;100.doi: 10.3760/cma.j.cn112137-20200308-00645
- Omrani AS, Saad MM, Abdul-Matin M, et al. Ribavirin and interferon alfa2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14(11):1090-5. doi: 10.1016/S1473-3099(14)70920-X
- Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020;382:1787-99. doi: 10.1056/NEJMoa2001282
- Warren TK, Wells J, Panchal RG, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 2014;508:402-5
- Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020. doi: 10.1001/jama.2020.6019
- Gandhi RT, Lynch JB, Del Rio C. Mild or Moderate COVID-19. N Engl J Med. 2020. doi: 10.1056/NEJMcp2009249
- Li C, Liu P, Guo S-S, Zhao Z-G. Study on the mechanism and treatment of gastrointestinal symptoms in patients with severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). Infect Dis Poverty. 2020;9(1):99. doi: 10.1186/s40249-020-00691-6
- Wei P-F. Diagnosis and treatment of pneumonia caused by novel coronavirus (trial version 7). General office of the Chinese health commission 2020. Chin Med J. 2020;133(9):1087-95. doi: 10.1097/CM9.0000000000000819
- Chen Y, Guo Y, Pan Y, and Zhao ZJ. Structure analysis of the receptor binding of 2019 nCoV. Biochem Biophys Res Commun. 2020;525(4):135-40. doi: 10.1016/j.bbrc.2020.02.071
- Hersberger L, Bargetzi L, Bargetzi A, et al. Nutritional risk screening (NRS 2002) is a strong and modifiable predictor risk score for short term and long term clinical outcomes: secondary analysis of a prospective randomized trial. Clin Nutr. 2019;39(9):2720-9. doi: 10.1016/j.clnu.2019.11.041
- Redd WD, Zhou JC, Hathorn KE, et al. Prevalence and Characteristics of Gastrointestinal Symptoms in Patients with SARS-CoV-2 Infection in the United States: A Multicenter Cohort Study. Gastroenterology. 2020;159(2):765-7. doi: 10.1053/j.gastro.2020.04.045
- Pan L, Mu M, Yang P, et al. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol. 2020;115(5):766-833. doi: 10.14309/ajg.0000000000000620
- Luo S, Zhang X, Xu H. Don’t Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19). Clin Gastroenterol Hepatol. 2020;18(7):1636-7. doi: 10.1016/j.cgh.2020.03.043